Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery
Active, not recruiting · Not applicable · NCT07027267
Conditions: Sinus Endoscopic Surgery, Turbinate
At a glance
- Research payments reported, 2025
- $146,403
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 50
About the trial
- Sponsor
- Spirair, Inc
- Tested
- Implantation of Spirair device into the middle turbinates (device), TurbAlign (device)
- Dates
- Started 2025-08-04; completion 2026-07-31
- Results posted
- Not yet
A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
From ClinicalTrials.gov, last updated 2026-04-27. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Spirair, Inc. reported $146,403 in research payments for this study in 2025 (12 payments).
Products named: Turbalign
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Sukhpreet S. Batra, M.D. ENT (Otolaryngology) · Chicago, IL
- Sam Khalili, MD ENT (Otolaryngology) · Arlington Heights, IL
- Adil A. Fatakia, M.D. ENT (Otolaryngology) · Marrero, LA
- Michael T. Yim, M.D. ENT (Otolaryngology) · Shreveport, LA
- Masayoshi Takashima, M.D. ENT (Otolaryngology) · Houston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Rush University Medical Center, IL $38,859
- Louisiana State University Health Sciences Center Shreveport $36,644
- Houston Methodist Academic Institute $34,134
- Tandem Clinical Research, LLC $21,576
- Northwest Community Hospital $15,190
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.